Genetron Holdings Ltd - ESG Rating & Company Profile powered by AI
Other companies in the rating peer group for Genetron Holdings Ltd are shown below. If you work at Genetron Holdings Ltd and you wish to use your ESG aseessment, please get in touch. This report of Genetron Holdings Ltd leverages data points from across the internet as well as from public documents by Genetron Holdings Ltd.
Genetron Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | Genetron Holdings Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
Frequently Asked Questions
Does Genetron Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes Genetron Holdings Ltd report the average age of the workforce?
Sign up for free to unlockDoes Genetron Holdings Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes Genetron Holdings Ltd offer flexible work?
Sign up for free to unlockDoes Genetron Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Genetron Holdings Ltd conduct supply chain audits?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Genetron Holdings Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose water use targets?
Sign up for free to unlockDoes Genetron Holdings Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid Genetron Holdings Ltd have a product recall in the last two years?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes Genetron Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Genetron Holdings Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose parental leave metrics?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes Genetron Holdings Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Genetron Holdings Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Genetron Holdings Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose its waste policy?
Sign up for free to unlockDoes Genetron Holdings Ltd report according to TCFD requirements?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose energy use targets?
Sign up for free to unlockDoes Genetron Holdings Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Genetron Holdings Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Genetron Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagnostic products, including 8-gene lung cancer assay, an IVD assay product to detect lung cancer; Genetron 3D biochip reading instrument; Genetron S5, a semiconductor-based NGS system, which detects the nucleotide through detecting the change in pH; Genetron Chef System; Genetron S2000 platform, a production-scale sequencer; and Onco PanScan, a genomic profiling service for various solid tumors. In addition, it offers IDH1 and TERT gene assays for glioma; thyroid basic assay for thyroid tumor; platelet-derived growth factor receptor alpha assay for GIST cancer; and HCCscan, a qPCR-based assay to detect hepatocellular carcinoma. Further, it provides development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies worldwide. The company has a strategic partnership with JD Health to create solutions for full-cycle cancer management. Genetron Holdings Limited was founded in 2015 and is headquartered in Beijing, the People's Republic of China.